Qube Research & Technologies (QRT)
SPRO icon

Qube Research & Technologies (QRT)’s Spero Therapeutics SPRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$1 – 4053
2024
Q2 		$1 Hold
1
– – ﹤0.01% 3708
2024
Q1 		$2 Hold
1
– – ﹤0.01% 4371
2023
Q4 		$1 Hold
1
– – ﹤0.01% 4282
2023
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 4044
2022
Q4 		– Sell
-15,948
Closed -$32K – 2962
2022
Q3 		$32K Sell
15,948
-1,716
-10% -$1.71K ﹤0.01% 2222
2022
Q2 		$13K Buy
+17,664
New +$51.4K ﹤0.01% 2308
2021
Q2 		– Sell
-24,878
Closed -$366K – 2768
2021
Q1 		$366K Buy
+24,878
New +$438K 0.01% 1350

Other funds holding SPRO

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SPRO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Spero Therapeutics (SPRO) in Q3 2024, closing a stake of 1 share — an estimated $1 sold.

Qube Research & Technologies (QRT) first reported a position in SPRO in Q1 2021 and held it in 7 quarters. The position peaked at $366K in Q1 2021. 46 funds tracked by Wall St. Rank hold SPRO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Spero Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 Spero Therapeutics share in Q3 2024, an estimated $1.
  • Qube Research & Technologies (QRT) first reported a position in Spero Therapeutics in Q1 2021 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Spero Therapeutics position peaked at $366K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.